169 related articles for article (PubMed ID: 38177667)
21. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
Sun Y; Gao D; Liu Y; Huang J; Lessnick S; Tanaka S
Oncogene; 2006 Feb; 25(7):1042-52. PubMed ID: 16247461
[TBL] [Abstract][Full Text] [Related]
22. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma.
Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F
Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645
[TBL] [Abstract][Full Text] [Related]
23. First cloned human immortalized adipose derived mesenchymal stem-cell line with chimeric SS18-SSX1 gene (SS-iASC).
Mihály D; Matula Z; Changchien YC; Papp G; Tátrai P; Sápi Z
Cancer Genet; 2017 Oct; 216-217():52-60. PubMed ID: 29025595
[TBL] [Abstract][Full Text] [Related]
24. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
D'Arcy P; Maruwge W; Ryan BA; Brodin B
Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
[TBL] [Abstract][Full Text] [Related]
25. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
26. Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability.
Benabdallah NS; Dalal V; Scott RW; Marcous F; Sotiriou A; Kommoss FKF; Pejkovska A; Gaspar L; Wagner L; Sánchez-Rivera FJ; Ta M; Thornton S; Nielsen TO; Underhill TM; Banito A
Nat Struct Mol Biol; 2023 Nov; 30(11):1640-1652. PubMed ID: 37735617
[TBL] [Abstract][Full Text] [Related]
27. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital.
Hill DA; Riedley SE; Patel AR; Shurtleff SA; Hyer J; Cain AM; Billups CA; Downing JR; Pappo AS
Pediatr Dev Pathol; 2003; 6(1):24-34. PubMed ID: 12469233
[TBL] [Abstract][Full Text] [Related]
28. Role of histone variants H2BC1 and H2AZ.2 in H2AK119ub nucleosome organization and Polycomb gene silencing.
Shen X; Chen C; Wang Y; Zheng W; Zheng J; Jones AE; Zhu B; Zhang H; Lyons C; Rijal A; Moley JA; Cao G; Liu K; Winn R; Dickinson A; Zhang K; Wang H
bioRxiv; 2024 Jan; ():. PubMed ID: 38293106
[TBL] [Abstract][Full Text] [Related]
29. The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies.
Boulay G; Cironi L; Garcia SP; Rengarajan S; Xing YH; Lee L; Awad ME; Naigles B; Iyer S; Broye LC; Keskin T; Cauderay A; Fusco C; Letovanec I; Chebib I; Nielsen PG; Tercier S; Cherix S; Nguyen-Ngoc T; Cote G; Choy E; Provero P; Suvà ML; Rivera MN; Stamenkovic I; Riggi N
Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361335
[TBL] [Abstract][Full Text] [Related]
30. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
31. The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.
Barco R; Garcia CB; Eid JE
PLoS One; 2009; 4(4):e5060. PubMed ID: 19337376
[TBL] [Abstract][Full Text] [Related]
32. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1.
Tsuda M; Watanabe T; Seki T; Kimura T; Sawa H; Minami A; Akagi T; Isobe K; Nagashima K; Tanaka S
Oncogene; 2005 Dec; 24(54):7984-90. PubMed ID: 16103879
[TBL] [Abstract][Full Text] [Related]
33. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
[TBL] [Abstract][Full Text] [Related]
35. Novel SS18-NEDD4 gene fusion in a primary renal synovial sarcoma.
Argani P; Zhang L; Sung YS; Bacchi C; Swanson D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2020 Mar; 59(3):203-208. PubMed ID: 31595587
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
37. The clinical implication of SS18-SSX fusion gene in synovial sarcoma.
Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y
Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186
[TBL] [Abstract][Full Text] [Related]
38. Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma.
Raquib AR; Hofvander J; Ta M; Nielsen TO
Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):531-539. PubMed ID: 35880992
[TBL] [Abstract][Full Text] [Related]
39. Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial Sarcoma.
Isfort I; Berthold R; Heinst L; Wardelmann E; Larsson O; Trautmann M; Hartmann W
Mol Cancer Res; 2023 Jun; 21(6):535-547. PubMed ID: 36920288
[TBL] [Abstract][Full Text] [Related]
40. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
